Bortezomib in Treating Patients With Lymphoproliferative Disorders

Clinical trial NCT00023764 · COMPLETED

Trial details

NCT number: NCT00023764
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma

Start date: 2001-06-01
Primary completion: 2009-03-01
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.